US Oversight of Venezuelan Oil May Aid Indian Pharma Exports and Recover Stalled Payments

A potential shift in US oversight of Venezuelan oil assets could resolve a dollar crunch for Indian pharmaceutical exporters, potentially unlocking millions in stalled payments. Venezuela was once a significant market for Indian pharma, with exports peaking at $250 million before the country's economic collapse led to substantial losses and company exits. While current exports are minimal, a revival of oil trade under US supervision might indirectly boost healthcare spending and allow companies to recover dues.